Position in SNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$28,758,939
-$4,171,222 QoQ
Shares Held
674,143
-1.4% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#46
of 712 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TODD ASSET MANAGEMENT LLC holds $250,852,520 across 11 Drug Manufacturers - General names. SNY ranks #5 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
282,442 | $71,073,704 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
421,984 | $53,313,458 | |
| 3 | NVS |
Novartis AG
|
317,429 | $49,747,472 | |
| 4 | AMGN |
Amgen Inc
|
108,134 | $39,157,483 | |
| 5 | SNY |
Sanofi
This page
|
674,143 | $28,758,939 | |
| 6 | NVO |
Novo Nordisk A S
|
134,460 | $6,446,012 | |
| 7 | JNJ |
Johnson & Johnson
|
3,288 | $835,053 | |
| 8 | PFE |
Pfizer Inc
|
27,801 | $669,448 |
All Filings in SNY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,758,939 | 674,143 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $32,930,161 | 683,482 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $33,399,939 | 689,227 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $32,996,292 | 699,074 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $32,332,240 | 669,266 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $36,483,251 | 657,830 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $31,595,858 | 655,108 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $37,977,823 | 658,994 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $32,041,491 | 660,377 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,837,995 | 531,646 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,058,574 | 383,241 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $18,907,670 | 352,492 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $19,206,133 | 356,329 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $19,333,738 | 355,269 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $16,846,035 | 347,843 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $6,960,777 | 183,082 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $26,261,397 | 524,913 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $17,082,101 | 332,725 | Shares | Defined | 2022-04-27 | |
| No filing history on record for this holder in this stock. | ||||||